About this trial
This pilot study assesses the feasibility and acceptability of delivering a brief Cognitive-Behavioral Resiliency treatment to a population of recently released parolees. This study will also give a preliminary indication if the treatment is associated with reliable improvements in adjustment symptoms and well-being for parolees.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
18 years or older
Speaks English
Been on parole for two years or less.
Score of 8.5 or higher (range 4 to 16) on the Adjustment Disorder New Module 4 (ADNM-4) screening tool (Ben-Ezra, et al., 2018).
Disqualifiers
None
Trial design
Parallel
Treatments tested in this trial
Cognitive Behavioral Therapy
BehavioralBrief Cognitive-Behavioral Therapy (CBT) focused on building resiliency in response to the effects of institutionalization
Treatment groups
Trial outcomes
Primary outcomes
Adjustment Disorder New Module 20
The ADNM-20 is a self-report measure consisting of two parts: a stressor list and an item list. It is a 20-item measure that ranges from 20 to 80. Participants will fill out stressors from their prison term and will then complete the items which are composed of a 4-point Likert scales from "Never" to "Often."
Flourishing Scale
The Flourishing Scale is an 8-item self-report measure (with a range of 8 to 56) of the respondent's self-perceived success in important areas such as relationships, self-esteem, purpose, and optimism. The scale provides a single psychological well-being score.
PROMIS Meaning and Purpose Short Form 8a
The PROMIS Meaning and Purpose is an 8-item self-report measure with a range of 8 to 40 that assess one's sense of life having purpose and that there are good reasons for living. Higher scores indicate hopefulness, optimism, goal-directedness, and feelings that one's life is worthy.
Secondary outcomes
PTSD Checklist 5
This is an 8-item abbreviated version of the PTSD Checklist 5, a self-report measure which ranges from 0 to 32 that assesses the DSM-5 symptoms of PTSD.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
University of California, Irvine
Lead sponsor
Massachusetts Institute of Technology
Collaborator